Donald Fry: Biotech tax credit more popular than ever, but the ‘rock-concert’ lines are gone

Posted by on in Blog
  • Font size: Larger Smaller
  • Hits: 6760
  • Subscribe to this entry
  • Print
  • Report this post
By Donald C. Fry

Last spring the Greater Baltimore Committee, in surveying members of Maryland’s bioscience community, asked a straightforward question: What is the single most important thing the state can do to ensure a robust bioscience industry?

The survey, conducted with MdBio, a division of the Tech Council of Maryland, yielded an overwhelmingly straightforward answer. Nurture more private investment in bioscience companies, said 70 percent of respondents, most of whom favored expanding the state’s biotech investment tax credit.

The other two most often-cited responses were to encourage collaboration in the bioscience sector and to support education and training in science-oriented disciplines.

The survey appears to confirm what members of the bioscience and economic development communities have been telling us anecdotally for several years – that the biotech tax credit is a highly popular and productive development tool. It leverages a strategic public commitment into private-sector investment that drives the growth of an industry looked upon by many, both locally and nationally, as an important driver of our state’s 21st century economy.

Maryland’s biotech investment tax credit first became available in 2007, when $6 million was budgeted annually for the incentive that enables investors to claim a 50 percent credit – up to $250,000 – against their state income taxes for eligible investments in qualified Maryland bioscience companies.

The new incentive prompted investors to begin lining up as early as 24 hours in advance of July 1, when the tax credits became officially available, in order to qualify for the limited amount of credits. The line of bioscience investors became a July 1 ritual for the next three years.

In 2008, Governor Martin O’Malley proposed to increase available biotech investment tax credits to $12 million in 2009 and to $24 million by 2013 as part of a plan to invest $1 billion in bioscience industry growth over 10 years. The state’s Life Sciences Advisory Board also recommended strengthening the biotech investment tax credit.

But the recession intervened, and in 2009 lawmakers kept funding for the tax credits at the $6 million level. In a last-minute budget item in the waning days of the 2010 General Assembly, lawmakers added $2 million, bringing available tax credits to $8 million for FY 2011, which began July 1.

Fortunately, hearing bioscience advocates’ pleas to find a better way to process and approve investors for the credits, the state launched an online applications process this year, which eliminated the annual “rock-concert” line of anxious investors. No doubt, it tested the July 1 capacity of network servers at the Maryland Department of Business and Economic Development, which administers the biotech tax credit.

The popularity of this tax credit serves as an example of what many consider to be the highest and best use of a state resource to generate private-sector business growth.

That’s not to say that the bioscience community doesn’t have some issues with the biotech investment tax credit. For instance drawbacks cited by survey respondents included that the tax credits are not available for investments to start-up companies and cannot currently be used for owners who invest in their own businesses.

Nevertheless, there is an overwhelming consensus among those on the ground in our state’s bioscience industry that the biotech investment tax credit is a highly effective development tool that has made a quantifiable difference in Maryland’s bioscience growth.

In a time when many state lawmakers are seeking ways to cut state business incentives, this is one incentive that is delivering measurable growth and for which availability should be expanded as soon as possible to the funding levels originally envisioned by the governor and his life science advisors.

Donald C. Fry is president and CEO of the Greater Baltimore Committee. He is a regular contributor to Center Maryland.

Previous Center Maryland columns by Donald C. Fry:

Bad timing for upcoming business tax report

For economic indicators, the ‘whipsaw’ effect continues

Do census data foretell a Baltimore city population rebound?

Remember the value of business after the election

New report ranks Baltimore among stronger regions to weather the recession

New living wage proposal: wrong idea, wrong time for Baltimore

Northeast needs more attention from federal rail planners

New national report has familiar ring for Maryland bioscience advocates

New report underscores Maryland’s work force development challenges

State’s health initiative: a ‘win-win’ for employers and their workforces

As Baltimore hikes taxes, are state’s counties next?

After the ‘fiber from heaven’ scramble, what’s next?

BRAC growth no longer a future event – it’s happening now

Economic development is a contact sport

Despite the recession, bioscience growth still percolates in Baltimore

State stumbles in enacting new education collective bargaining process

Wind power has potential in Maryland, but solar emerges as early renewable option

It's not good to be clueless in cyberspace

Amid fiscal shuffle, Maryland lawmakers pass measures to spur business growth

Thankfully, Baltimore leads with substance over style in luring Google

Leave damaging transportation provisions out of the budget

Amended budget continues recession-induced fund shifts and stimulus rescue

General Assembly setting stage for combined reporting push in 2011

Wrong timing for proposal to change Baltimore City school board

Baltimore City isn’t alone in facing pension funding challenges

A government investment program that delivers

Proposed transportation fund raid -- a bad habit continues

Where's the outrage over crime?

Small business is where innovation lives
Rate this blog entry:

Donald C. Fry has been the president and CEO of the Greater Baltimore Committee (GBC), the central Maryland region's most prominent organization of business and civic leaders, since November 2002.

Under Don’s leadership, the GBC is recognized as a knowledgeable and highly credible business voice in the Baltimore region, Annapolis and Washington, D.C. on policy issues and competitive challenges facing Maryland. Its mission is to apply private-sector leadership to strengthening the business climate and quality of life in the region and state.

Fry served as GBC executive vice president from 1999 to 2002. From 1980 to 1999 Fry was engaged in a private law practice in Harford County. During this time he also served in the Maryland General Assembly. He is one of only a handful of legislators to have served on each of the major budget committees of the General Assembly.

Serving in the Senate of Maryland from 1997 to 1998, Fry was a member of the Budget and Taxation Committee. As a member of the House of Delegates from 1991 to 1997 Fry served on the Ways and Means Committee and on the Appropriations Committee.

Fry is a 1979 graduate of the University of Baltimore School of Law. He earned a B.S. in political science from Frostburg State College.